Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting ...Middle East

CAMBRIDGE, Mass., April 10, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today presented data on SYNB1891 for the treatment of solid tumors and lymphoma during the American Association...

Hence then, the article about synlogic presents data from synb1891 phase 1 trial at american association for cancer research aacr annual meeting was published today ( Saturday 10/04/2021 - 05:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting )

Also on site :

• DoE Deletes Webpage Instructing People To Lower Thermostat to 78
• People Who Watch ‘Love Island’ Every Day Share This 1 Surprising Trait, Psychologist Says
• Is Walmart Open on Fourth of July 2026?